IL1RAP and acute myeloid leukemia: Afterwards, they were able to efficiently transduce T cells derived from AML patients with anti-IL-1RAP CAR, and IL-RAP CAR-T cells efficiently killed AML tumor lines and primary samples in vitro and in vivo, with no toxicity against healthy tissues or HSCs.